GOLDENWELL BIOTECH, INC. (GWLL) Operating income 2021–2025
GOLDENWELL BIOTECH, INC. (GWLL) annual operating income history from SEC filings — each fiscal year as reported.
-$113,326FY2025 · since FY2021: -$118,267 → -$113,326
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$113,326 | +7.9% |
| FY2024 | -$123,098 | -6.3% |
| FY2023 | -$115,826 | +88.2% |
| FY2022 | -$985,105 | -733.0% |
| FY2021 | -$118,267 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GWLL financial trends
GWLL RevenueGWLL Net incomeGWLL Net marginGWLL Gross profitGWLL Gross marginGWLL Operating marginGWLL Operating cash flowGWLL Free cash flowGWLL Capital expendituresGWLL Return on equityGWLL Stock buybacksGWLL Dividends paidGWLL Total assetsGWLL Total liabilitiesGWLL Shareholders’ equityGWLL overview →